Digestible Elderberry Immune Support with Flavonoid Antioxidants
Eldermune™ is an innovative new NutriScience product containing elderberry juice concentrate combined with Sunfiber® (partially hydrolyzed guar fiber). This combination of elderberry for immune support and Sunfiber®, a prebiotic, soluble, dietary fiber, has synergistic effects on digestibility to enhance the absorption of nutrients. Eldermune™ is available in both conventional and Certified Organic grades.
Black Elderberry has been studied for its antibacterial and antiviral activity; it was found to be active against human pathogenic bacteria as well as influenza viruses1. The Cleveland Clinic has long recommended elderberry for colds and flu2.
Eldermune™ is labeled as a dietary supplement for immune support.
Eldermune™ takes the concept of a high potency elderberry concentrate to the next level by using a patented, low temperature drying process and adding back in the important fiber component. Eldermune™ is processed in a way that helps it to overcome some common challenges with juice powders. Juice concentrate powders are spray dried on maltodextrin; the spray drying process itself is hot, which causes the loss of activity in some of the key antioxidants –polyphenols and anthocyanins, and Vitamin C – which are fundamental to elderberry’s potency. During the juicing process, the fiber from the elderberry fruit is removed. Therefore, the juice concentrate is devoid of this important component.
Eldermune™ utilizes a unique and different drying process3 to create a combination powder of elderberry juice concentrate and Sunfiber®, rather than using maltodextrin. The Sunfiber® prebiotic fiber works synergistically with the elderberry to support digestion and the unique processing helps to maintain higher levels of key antioxidants.
The recommended dose for Eldermune™ is 100 – 1,000 mg / serving. The product can be formulated into capsules for immune support between 100 and 500 mg. Eldermune™ works well in a syrup to compete against the leading brands at a dose of 1,000 mg.
In the Press:
(1.) Reference 1
(2.) Reference 2
(3.) Reference 3